Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pivotal Trial for an Automated AI-based System for Detection of Diabetic Retinopathy

NCT: NCT07844317 · RECRUITING

NCT IDNCT07844317
StatusRECRUITING
Start Date2026-08-24
Completion2027-08-31
SponsorDigital Diagnostics, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Assessment of an autonomous AI system for diabetic retinopathy detection in adults with diabetes using retinal imaging.

Frequently Asked Questions

What is Pivotal Trial for an Automated AI-based System for Detection of Diabetic Retinopathy?

Pivotal Trial for an Automated AI-based System for Detection of Diabetic Retinopathy is a clinical trial registered under NCT07844317. Current status: RECRUITING.

What is the status of NCT07844317?

The current status of NCT07844317 (Pivotal Trial for an Automated AI-based System for Detection of Diabetic Retinopathy) is: RECRUITING.

When did Pivotal Trial for an Automated AI-based System for Detection of Diabetic Retinopathy start?

Pivotal Trial for an Automated AI-based System for Detection of Diabetic Retinopathy started on 2026-08-24.

Related Devices

K203629IDx-DRDigital Diagnostics, Inc. K213037IDx-DR v2.3Digital Diagnostics, Inc. K190954Fundus CameraChongqing Bio Newvision Medical Equipment , Ltd. K202097Fundus CameraHuvitz Co., Ltd. K210197NFC-600 Automated Portable Retinal CameraCrystalvue Medical Corporation

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑